Publication & Citation Trends
Publications
0 total
Abstract 100: Real-world clinical outcomes associated with first line treatments in patients with advanced non-small cell lung cancer without EGFR mutation or ALK rearrangement based on AACR GENIE
Cited by 0
Semantic Scholar
Cost-effectiveness of Afatinib versus Erlotinib in the First-line Treatment of Patients with Metastatic Non-small Cell Lung Cancer with EGFR Exon 19 Deletion Mutations
Cited by 9
Semantic Scholar
Costs associated with adverse events in patients with metastatic renal cell carcinoma OA
Cited by 12
Semantic Scholar
Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network OA
Cited by 25
Semantic Scholar
Economic burden of adverse events in patients with metastatic renal cell carcinoma.
Cited by 20
Semantic Scholar
Research Topics
Economic and Financial Impacts of Cancer
(9)
Chronic Obstructive Pulmonary Disease (COPD) Research
(7)
Asthma and respiratory diseases
(6)
Renal cell carcinoma treatment
(6)
Influenza Virus Research Studies
(5)
Affiliations
ECRI Institute
West Virginia University
Research Triangle Park Foundation
Amgen (United States)
GlaxoSmithKline (United Kingdom)